Get started
Work

Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience

Year: 2014
Type: article
Study design: Observational Study
Abstract: Meeting abstracts In two Phase III randomized trials in MM, Ipi improved median overall survival (OS) [[1][1], [2][2]]. Here, we evaluate OS and characterize post-Ipi treatment patterns among long-term survivors from a single-institution cohort of patients (pts) treated with Ipi. Through a search
DOI: 10.1186/2051-1426-2-s3-p117
Authors: David B Page, Jarushka Naidoo, Parisa Momtaz, Kita Bogatch, Deborah Kuk, Katherine Panageas, Jianda Yuan, Jedd D Wolchok, Michael Postow
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2014588238
FWCI: 0.161
Cites: 2
Cited by: 1
Related to: 10